In cases of ovarian cancer complications, even BRCA2 exhibit sufficiently high odds ratio of 3.06, but BRCA1 stood out with an odds ratio of 19.33, indicating a notably high probability. This evidence concerns the gene BRCA2 and ovarian cancer.